Shorted
Neurizon Therapeutics logo
NUZ
Pharmaceuticals, Biotechnology & Life Sciences

Neurizon Therapeutics

Short interest
0.01%
−0.02 pp 30d
as of 27 Dec 2024
Reported shorts
43.4K
Shares on issue
491.906M

Neurizon Therapeutics (NUZ) company profile

Profile, insiders and operations

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2026-09-17Unknown Director
buy
---
2026-09-14Sergio Duchini
buy
372,960$0.080$29,960.01
2026-07-01Unknown Director
buy
---
2026-06-30Marcus Hughes
buy
576,940$0.059$34,212.52
2026-05-04Unknown Director
buy
---
2026-04-30Michael Thurn
other
500,000--
2026-03-26Unknown Director
buy
---
2026-03-19Sergio Duchini
buy
1,875,000$0.080$150,000
2026-02-03Unknown Director
buy
---
2026-01-29Marcus Hughes
buy
750,000$0.080$60,000
2026-01-23Unknown Director
buy
---
2026-01-19Michael Thurn
other
1,000,000--
2026-01-02Unknown Director
buy
---
2025-12-23Sergio Duchini
buy
416,667$0.120$50,000.04
2025-02-07Unknown Director
buy
---
2025-01-31Sergio Duchini
exercise options
1,560,000--
2024-11-08Unknown Director
buy
---
2024-11-01Sergio Duchini
buy
6,974,947$0.036$250,000
2024-07-29Unknown Director
buy
---
2024-07-25Dr. Michael Thurn
buy
157,895$0.190$30,000.05

NUZ intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required